Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients: Translational Research
Autor: | Batus, M., Pithadia, R., Kubasiak, J., Fhied, C., Ibrahem, Z., Melinamani, S., Fughhi, I., Lie, W., Basu, S., Fidler, M., Bonomi, P.D., Borgia, J.A. |
---|---|
Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 15 November 2014 90(5) Supplement:S75-S75 |
Databáze: | ScienceDirect |
Externí odkaz: |